NCT01375530 Screening Volunteers for Clinical Trials
| NCT ID | NCT01375530 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Condition | Screening |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2011-08-16 |
| Primary Completion | — |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2011-08-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: \- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work. Objectives: \- To screen healthy volunteers for clinical trials at the NIAID VRC. Eligibility: \- Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies. Design: * Screening for healthy volunteers to participate in clinical trials is an ongoing process. * Volunteers will be asked about their medical history, including sexual activity and drug use, and a detailed physical exam will be performed. * Blood and urine samples may be collected, and possibly other tests as needed to evaluate the volunteer's health status. * Volunteers will not receive any investigational product in this screening protocol.
Eligibility Criteria
* INCLUSION CRITERIA: Age: 18 years of age or older Able and willing to complete the informed consent process Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions EXCLUSION CRITERIA: A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being Known to be pregnant or breast-feeding
Contact & Investigator
Lasonji A Holman, C.R.N.P.
PRINCIPAL INVESTIGATOR
National Institute of Allergy and Infectious Diseases (NIAID)
Frequently Asked Questions
Who can join the NCT01375530 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01375530 currently recruiting?
Yes, NCT01375530 is actively recruiting participants. Contact the research team at vrcrecruitment@mail.nih.gov for enrollment information.
Where is the NCT01375530 trial being conducted?
This trial is being conducted at Atlanta, United States, Baltimore, United States, Bethesda, United States, Philadelphia, United States.
Who is sponsoring the NCT01375530 clinical trial?
NCT01375530 is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). The principal investigator is Lasonji A Holman, C.R.N.P. at National Institute of Allergy and Infectious Diseases (NIAID). The trial plans to enroll 4,000 participants.